Pulmonary Arterial Hypertension (PAH) Treatment Market - Demand, Size and Competitive Analysis

The Pulmonary Arterial Hypertension (PAH) Treatment Market is poised for steady growth, projected to expand from USD 5,820 million in 2024 to approximately USD 6,926.76 million by 2032, with a CAGR of 2.2% during the forecast period.

肺动脉高压（PAH）治疗市场预计将呈现稳定增长态势，预计从2024年的58.2亿美元扩大至2032年约69.27亿美元，在预测期内实现2.2%的年复合增长率。